Reported Jan 28, 2026 · Ongoing
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine…
Cipla USA, Inc.
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Cipla USA, Inc. · 10 Independence Blvd · Warren, NJ · 07059-2730
Is this the product you have?
Diclofenac Sodium Topical Gel1%NET WT 100 g (3.53 oz)
- Manufactured byDPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215
- NDC76282-103-39
- Lot codes and dates
- Batch XHBG; Exp. 08/31/2027
- Amount recalled
- 92,376 tubes
Where it was sold
- Nationwide
Why it was recalled
Failed PH Specifications
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Cipla USA, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.